Ptc Therapeutics (PTCT) EPS (Weighted Average and Diluted): 2012-2025
Historic EPS (Weighted Average and Diluted) for Ptc Therapeutics (PTCT) over the last 7 years, with Sep 2025 value amounting to $0.20.
- Ptc Therapeutics' EPS (Weighted Average and Diluted) rose 114.39% to $0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.56, marking a year-over-year increase of 244.11%. This contributed to the annual value of -$4.73 for FY2024, which is 43.49% up from last year.
- Per Ptc Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.20 for Q3 2025, which was up 124.10% from -$0.83 recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' EPS (Weighted Average and Diluted) peaked at $10.04 during Q1 2025, and registered a low of -$2.66 during Q2 2023.
- In the last 3 years, Ptc Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$1.29 in 2024 and averaged -$0.33.
- Per our database at Business Quant, Ptc Therapeutics' EPS (Weighted Average and Diluted) dropped by 26.79% in 2022 and then soared by 936.67% in 2025.
- Ptc Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$2.02 in 2021, then declined by 16.83% to -$2.36 in 2022, then rose by 12.71% to -$2.06 in 2023, then spiked by 58.74% to -$0.85 in 2024, then surged by 114.39% to $0.20 in 2025.
- Its last three reported values are $0.20 in Q3 2025, -$0.83 for Q2 2025, and $10.04 during Q1 2025.